Impact

Impact-Site-Verification: 1280325212

Tuesday, 11 March 2025

Annual jab for HIV protection passes trial hurdle

Lenacapavir, which stops HIV from replicating inside cells, has passed early safety tests.
Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)